PPrivate Fund Data
CompaniesFundsPeopleRankingsScreener

Redmile Biopharma Investments III, L.P.

Private Equity FundFund ID 805-5445849187Delaware, United States
Gross assets
$1.13B
Min. investment
$5M
Beneficial owners
330
Size rank
Top 7%
Audited
Yes
Structure
Standalone

About this fund

Redmile Biopharma Investments III, L.P. is a private equity fund managed by Redmile Group, LLC. The fund reports $1.1 billion in gross assets, placing it among the top 7% of private funds by size. The stated minimum investment is $5 million. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.

Fund details

Fund ID805-5445849187
Fund typePrivate Equity Fund
3(c)(1) exclusionNo
3(c)(7) exclusionYes
Master fundNo
Feeder fundNo
Fund of fundsNo
Relies on exemption from registrationYes
Annual auditYes
Prepared per GAAPYes
Sub-advisedNo
% of assets independently valued70%

Other funds from this manager

FundTypeGross assets
Redco II Master Fund, L.P.Hedge$1.56B
Redmile Capital Offshore II Master Fund, Ltd.Hedge$738.2M
Redmile Biopharma Investments II, L.P.Venture Capital$661M
See all 17 funds from this manager — unlock the full record.
Join to unlock · $37/mo

Frequently asked questions

How large is Redmile Biopharma Investments III, L.P.?

Redmile Biopharma Investments III, L.P. reports $1.1 billion in gross assets, among the top 7% of private funds by size.

What is the minimum investment for Redmile Biopharma Investments III, L.P.?

The stated minimum investment is $5 million.

Who manages Redmile Biopharma Investments III, L.P.?

Redmile Biopharma Investments III, L.P. is managed by Redmile Group, LLC.

Does Redmile Biopharma Investments III, L.P. disclose returns?

No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.

Manager

R
Larkspur, CA

Service providers

Prime broker
Administrator
Marketer

Reported gross assets

$1.13B▲ 17%
Mar '25 — $972.2MApr '25 — $972.2MMay '25 — $972.2MJun '25 — $972.2MJul '25 — $972.2MAug '25 — $972.2MSep '25 — $972.2MOct '25 — $972.2MNov '25 — $972.2MDec '25 — $972.2MJan '26 — $972.2MFeb '26 — $972.2MMar '26 — $1.13BApr '26 — $1.13BMay '26 — $1.13BJun '26 — $1.13B
Mar '25Form ADV, monthlyJun '26

How this fund compares

Gross assetsTop 7%
Larger than 93% of 67,041 private funds
Gross assets vs Private Equity FundsTop 6%
Larger than 94% of 31,066 private equity funds
Minimum investmentTop 17%
Higher than 83% of funds reporting a minimum

Investor base

Adviser & related persons5%
Funds of funds18%
Non-U.S. persons46%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.